Safety of Levocloperastine During Pregnancy

General Principles

Most medications, including antitussives, should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, following the general principle of medication use in pregnancy 1

For pregnant women requiring cough management, medications with established safety profiles should be considered first 2
Second-generation antihistamines may be preferable if an antihistamine is needed for cough management during pregnancy due to their better-documented safety profile 3

The decision to use any medication during pregnancy must balance maternal benefit against potential fetal risk 2, 1
Non-pharmacological approaches to cough management (hydration, humidification, honey for non-diabetic patients) should be considered first-line before resorting to medications with limited safety data 2

If cough is severe and significantly impacts maternal health or is a symptom of a more serious condition, the risk-benefit assessment may change, and treatment becomes more necessary 2
Always consider the underlying cause of the cough, as treating the primary condition may be more appropriate than symptomatic management 2
Any medication use during pregnancy should be discussed with a healthcare provider who can provide individualized recommendations based on the specific clinical situation 1, 3

Avoid levocloperastine during pregnancy, especially in the first trimester when organogenesis occurs 1
Consider safer alternatives with established pregnancy safety data if pharmacological treatment is necessary 3
Document the discussion of risks and benefits if treatment is deemed necessary despite limited safety data 1
Monitor for any adverse effects if the medication must be used in situations where benefits clearly outweigh potential risks 2